Impact ledger
iShares Biotechnology ETF (IBB)
17 events mapped to this ticker since 2026-06-15.
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-07-14 | Event | Increased funding for a biotech company, potentially signaling investor confidence in the broader biotech sector, especially in neurological disorders. | Bullish | 1-5d | 0.30 |
| 2026-07-04 | Event | General sentiment indicator for the biotech sector; large capital raises can signal investor confidence or, conversely, a need for cash in a challenging environment. | watch | 1-5d | 0.30 |
| 2026-06-29 | Event | Similar to XBI, IBB provides broad exposure to the biotechnology sector. M&A activity can influence overall sector sentiment and valuations. | watch | 1-3m | 0.30 |
| 2026-06-29 | Event | General sentiment towards biotech M&A, potential for sector-wide re-rating of similar assets. | watch | 1-3m | 0.20 |
| 2026-06-25 | Event | Similar to XBI, positive news from a constituent company can provide a minor uplift to the broader biotechnology sector ETF. | Bullish | 1-5d | 0.20 |
| 2026-06-23 | Event | Positive sentiment for the broader biotechnology sector due to successful capital raise for a pre-clinical/early-clinical stage company, indicating investor confidence. | Bullish | 1-5d | 0.60 |
| 2026-06-23 | Event | Successful IPOs can signal broader investor appetite for the biotechnology sector, potentially influencing sentiment for related ETFs. | watch | 1-5d | 0.20 |
| 2026-06-23 | Event | Very minor negative sentiment spillover due to a constituent company's bankruptcy, potentially increasing risk aversion in the broader biotech sector. | Bearish | 1-5d | 0.10 |
| 2026-06-17 | Event | Similar to XBI, but with potentially less direct impact due to IBB's broader and often larger-cap holdings. Still, negative news from a clinical-stage company can contribute to overall sector cautiousness. | Bearish | 1-5d | 0.10 |
| 2026-06-15 | Event | Minor sentiment spillover from a small-cap biotech company's restructuring, potentially indicating broader industry pressures. | watch | 1-3m | 0.10 |
| 2026-06-15 | Event | Similar to XBI, minor sentiment spillover from a clinical trial failure, potentially increasing general risk aversion in the biotech space. | Bearish | 1-5d | 0.10 |
| 2026-06-15 | Event | Minor negative sentiment spillover from a clinical trial failure in the biotech sector. | Bearish | 1-5d | 0.05 |
| 2026-06-15 | Event | General negative sentiment spillover to the broader biotechnology sector, particularly for clinical-stage companies. | Bearish | 1-5d | 0.15 |
| 2026-06-15 | Event | Minor negative sentiment spillover from a clinical trial failure in the small-cap biotech space. | Bearish | 1-5d | 0.05 |
| 2026-06-15 | Event | Minor sentiment impact on the broader biotechnology sector, reflecting general market concerns about capital efficiency. | watch | 1-3m | 0.10 |
| 2026-06-15 | Event | Indirect sentiment impact on the broader biotechnology sector, similar to XBI but potentially less pronounced due to broader diversification. | Bearish | 1-5d | 0.15 |
| 2026-06-15 | Event | Similar to XBI, general negative sentiment in the biotech sector due to a clinical trial setback, though IBB has a broader and often larger-cap exposure, potentially dampening the direct impact. | Bearish | 1-5d | 0.15 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for IBB, start a trial or view the IBB entity page.